Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
Unknown
60 enrolled
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Unknown
529 enrolled
Hepatobiliary Tumors Tissue Samples Acquisition
Unknown
450 enrolled
TELOGNOSTIC
Unknown
300 enrolled
Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Phase 3 Unknown
3,400 enrolled
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Phase NA Unknown
30 enrolled
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
Unknown
1,800 enrolled
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
Unknown
800 enrolled
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Phase 1 Unknown
20 enrolled
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
Phase 2 Unknown
225 enrolled
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
Phase NA Unknown
200 enrolled
Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
Phase 1 Unknown
30 enrolled
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
Unknown
2,000 enrolled
Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant
Unknown
125 enrolled
Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Phase NA Unknown
75 enrolled
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
Phase 2 Unknown
60 enrolled
GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma
Phase 2 Unknown
30 enrolled
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
Unknown
957 enrolled
Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia
Phase 2 Unknown
66 enrolled
Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy
Phase 2 Unknown
47 enrolled
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
Unknown
200 enrolled
Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
Phase 2 Unknown
35 enrolled